Oral propranolol seems safe for infantile hemangioma

May 31, 2018

(HealthDay)—The safety profile of oral propranolol seems to be good for children with infantile hemangioma, according to a study published online May 29 in Pediatrics.

Catherine Droitcourt, M.D., from the University of Rennes in France, and colleagues used the French National Health Insurance system to perform a survey of a nationwide cohort of children aged <3 years with infantile hemangioma with at least one delivery of oral propranolol between July 2014 and June 2016. Standardized morbidity ratios (SMRs) were calculated using a representative sample of nonexposed children from the same database. The main analysis was conducted on 1,484 healthy children, free of any prespecified underlying disease and on 269 children with one underlying disease (cardiovascular, respiratory, or metabolic disease).

The researchers found that two cardiovascular events, 51 respiratory events, and three metabolic events were observed in the healthy population (SMR, 2.8 [0 to 6.7], 1.7 [1.2 to 2.1], and 5.1 [0 to 10.9], respectively). In patients with an underlying disease, usually congenital heart disease, there were 11 cardiovascular events (SMR, 6 [2.5 to 9.6]). Among children with underlying disease, SMRs were not significantly elevated for respiratory or metabolic events.

"In this study on a large continuous nationwide claims database, we confirm the safety profile of oral propranolol in healthy children to be good," the authors write.

Explore further: Propranolol effective for infantile hemangioma

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Propranolol effective for infantile hemangioma

February 19, 2015
(HealthDay)—Propranolol (Inderal) appears to be effective in treating infantile hemangiomas, according to research published in the Feb. 19 issue of the New England Journal of Medicine.

Serious adverse drug reactions rare from certain treatment for vascular tumor in infants

January 26, 2016
Sorilla Prey, M.D., of the Université de Bordeaux, France and colleagues examined the safety of propranolol therapy in treating infantile hemangioma, a vascular tumor characterized by rapid growth during the first weeks ...

Review supports early multimodal Tx for infantile hemangioma

May 17, 2017
(HealthDay)—Early multimodality treatment seems to achieve best results for children with infantile hemangiomas of the nose, according to research published online May 11 in JAMA Facial Plastic Surgery.

Rx errors up with generic propranolol for hemangioma

April 28, 2017
(HealthDay)—Physicians prescribing propranolol in a single concentration of 4.28 mg/mL for infantile hemangioma (IH) report fewer prescribing errors than those prescribing generic propranolol, according to a research letter ...

Rebound growth for one in four with infantile hemangioma

March 11, 2016
(HealthDay)—About 25 percent of patients with infantile hemangioma (IH) have rebound growth, according to a study published online March 7 in Pediatrics.

Understanding of infantile hemangiomas is improving

December 27, 2012
(HealthDay)—Improved understanding of the pathogenesis of infantile hemangiomas (IHs) is leading to better treatment options, according to a review published online Dec. 24 in Pediatrics.

Recommended for you

The inequalities of prenatal stress

August 14, 2018
Exposure to an acute stress in utero can have long-term consequences extending into childhood – but only among children in poor households, according to a new Stanford study that looked at the long-term impact of acute, ...

Promoting HPV vaccine doesn't prompt risky sex by teens: study

August 13, 2018
(HealthDay)—Controversial state laws that promote vaccinating kids against the human papillomavirus (HPV) do not increase the likelihood that teens will engage in risky sexual behavior, a new study contends.

Grip strength of children gives clues about their future health

August 13, 2018
While other studies have shown that muscle weakness as measured by grip strength is a predictor of unhealthy outcomes—including cardiovascular and metabolic diseases, disability and even early mortality—this is the first ...

Prenatal vitamin D pills won't boost babies' growth: study

August 9, 2018
(HealthDay)—For pregnant women who are vitamin D-deficient, vitamin supplements won't improve the growth of their fetus or infant, Canadian researchers report.

Giving kids plates with segments and pictures caused them to eat more vegetables

August 8, 2018
A pair of researchers at the University of Colorado has found that preschool kids ate more vegetables when presented with segmented plates with pictures of fruits and vegetables on them. In their paper published in JAMA Pediatrics, ...

Is too much screen time harming children's vision?

August 6, 2018
As children spend more time tethered to screens, there is increasing concern about potential harm to their visual development. Ophthalmologists—physicians who specialize in medical and surgical eye care—are seeing a marked ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.